Clinical rate and duration of response for RAI-refractory well-differentiated thyroid cancer #hncs16

Clinical rate and duration of response for RAI-refractory well-differentiated thyroid cancer #hncs16

User Photo
ASTROHN2016

4 years
187 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. Keith C. Bible, MD or the Mayo Clinic discusses the clinical benefit rate and duration of response for first and second line therapy in RAI-refractory well-differentiated thyroid cancer at ASTRO Head and Neck Symposium
Up Next Autoplay
User Photo